Skip to main content
. 2022 Aug 15;61(16):2405–2415. doi: 10.2169/internalmedicine.8560-21

Figure 1.

Figure 1.

Changes in the BMD during denosumab therapy. Data are expressed as the median with 25th to 75th percentiles. *: p<0.05 versus baseline by Dunnett’s multiple comparison test